Somatostatin receptor subtype expression in human thyroid tumours

Hormone and Metabolic Research

Volumn 42, Issue 4, 2010, Pages 237-240

  Klagge, A ^a   Krause, K ^a   Schierle, K ^a   Steinert, F ^b   Dralle, H ^c   Fuhrer, D ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Centre for Minimally Invasive and Laparoscopic Surgery   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cancer; Neoplasia; Octreotide; Somatostatin analogues

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; MESSENGER RNA; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; FOLLICULAR CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID TUMOR; UPREGULATION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS;

EID: 77950494583     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1243636     Document Type: Article

References (12)

1. Reubi JC, Krenning E, Lamberts SW, Kvols L. Somatostatin receptors in malignant tissues. J Steroid Biochem Mol Biol 1990 20 1073-1077
2. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D, Lubbert H. Molecular pharmacology of somatostatin-receptor subtypes. Ann N Y Acad Sci 1994 733 138-146
3. Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H, Srikant CB. The somatostatin receptor family. Life Sci 1995 57 1249-1265
4. Druckenthaner M, Schwarzer C, Ensinger C, Gabriel M, Prommegger R, Riccabona G, Decristoforo C. Evidence for Somatostatin Receptor 2 in Thyroid Tissue. Regul Pept 2007 138 32-39
5. Ain KB, Taylor KD, Tofiq S, Venkataraman G. Somatostatin Receptor Subtype Expression in Human Thyroid and Thyroid Carcinoma Cell Lines. J Clin Endocrinol Metab 1997 82 1857-1862
6. Forssell-Aronsson EB, Nilsson O, Bejegard SA, Kolby L, Bernhardt P, Molne J, Hashemi SH, Wangberg B, Tisell LE, Ahlman H. 111In-DTPA-D-Phe1-Octreotide binding and somatostatin receptor subtypes in thyroid tumors. J Nucl Med 2000 41 636-642
7. Weckbecker G, Raulf F, Stolz B, Bruns C. Somatostatin Analogs for Diagnosis and Treatment of Cancer. Pharmacol Ther 1993 60 245-264
8. Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Macke HR. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic Use. Eur J Nucl Med 2000 27 273-282
9. Corleto VD, Falconi M, Panzuto F, Milione M, De Luca O, Perri P, Cannizzaro R, Bordi C, Pederzoli P, Scarpa A, Delle FG. Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Neuroendocrinology 2009 89 223-230
10. Papotti M, Bongiovanni M, Volante M, Allia E, Landolfi S, Helboe L, Schindler M, Cole SL, Bussolati G. Expression of somatostatin receptor types 15 in 81 cases of gastrointestinal and pancreatic rndocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch 2002 440 461-475
11. Lamberts SW, Hofland LJ; van Koetsveld PM, Reubi JC, Bruining HA, Bakker WH, Krenning EP. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: Consequences with Regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab 1990 71 566-574
12. Nilsson O, Kolby L, Wangberg B, Wigander A, Billig H, William-Olsson L, Fjalling M, Forssell-Aronsson E, Ahlman H. Comparative studies on the expression of somatostatin receptor subtypes, Outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours. Br J Cancer 1998 77 632-637